^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    AmoyDx® HRD Focus Panel

    Company:
    Amoy Diagnostics
    Type:
    Laboratory Developed Test
    Related tests:
    The AmoyDx® HRD Focus Panel (Reversible Terminator Sequencing) is a next generation sequencing-based in vitro diagnostic test that determines a patient’s HRD status by detecting SNVs and InDels in whole coding regions and intron/exon boundaries of the BRCA1 and BRCA2 genes, and determining a genomic scar score (GSS) using DNA isolated from neutral formalin-fixed paraffin-embedded (FFPE) tissue samples.
    Cancer:
    Ovarian Cancer
    Gene:
    BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), HRD (Homologous Recombination Deficiency)
    Method:
    Next-Generation Sequencing (NGS)